The resubmitted NDA is based on a comprehensive development programme that inclu...
LPX-TI641 is being developed to treat neuro-autoimmune indications including mul...
The combined company will be named enGene Holdings on completion of the deal.
LMN-201 is given concomitantly with standard antibiotics and eight weeks thereaf...
Rivoceranib is an oral TKI, while camrelizumab is a PD-1 inhibitor.
Leaders must renew their commitment to eradicating NTDs if they are to achieve t...
Whilst medicine shortages are a global health problem, European countries are be...
The company aims to start the Phase II study of its lead compound zelquistinel i...
The Federal Trade Commission is widening its probe into PBMs and their impact on...
Senators warned the country’s largest Medicare Advantage insurers that they cann...
In a new trial, providing contacts of people with leprosy with a single dose of ...
A House panel took its first steps toward reining in how hospitals are paid and ...
Federal judges questioned the FDA's authority during an appeals court hearing ov...
The FDA could take longer to write regulations and make decisions if the Supreme...
CVS first revealed its clinical trials unit in May 2021, which had a focus on dr...
The FTC's suit to block Amgen from acquiring Horizon Therapeutics cast a spotlig...
